Trinity Biotech (TRIB) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Trinity Biotech PLC has released its unaudited condensed consolidated financial statements for the period ending June 30, 2024, showing a significant increase in total assets to $94,355,000 from $59,435,000 at the end of the previous year. This financial growth is reflected in the rise of both non-current and current assets, including goodwill, intangible assets, and inventories. Shareholders will note an increase in share capital and share premium, despite a continued accumulated deficit.
For further insights into TRIB stock, check out TipRanks’ Stock Analysis page.
